Universal Health Services, Inc. UHS SPXR3KPHARMA

Q: What is the current share price of Universal Health Services, Inc. (UHS)?

As of 2026-09-07 16:24 PDT, Universal Health Services, Inc. (UHS) trades at $169.14 on NYSE. Its 52-week range is $141.00 to $243.12.

Q: What is the market capitalisation of UHS?

Universal Health Services, Inc. (UHS) has a market capitalisation of $9.01B on NYSE.

Q: What is the P/E ratio of UHS?

UHS trades at a trailing price-to-earnings (P/E) ratio of 6.90. The industry average P/E is 25.17. Its price-to-book (P/B) ratio is 1.38.

Q: Does UHS pay a dividend?

Universal Health Services, Inc. (UHS) currently offers a dividend yield of 0.47%.

Q: What is the return on equity (ROE) of UHS?

UHS has a return on equity (ROE) of 20.95%. Its return on capital employed (ROCE) is 16.23%.

Q: Is UHS a good stock to buy?

This page provides a data-driven analysis of Universal Health Services, Inc. (UHS), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Healthcare · Medical Care Facilities · United States

https://uhs.com

Company Profile ↓

$169.14

-4.85% 1Y

Mkt Cap$9.01B

P/E6.90

P/B1.38

Div. Yield0.47%

52W High$243.12

52W Low$141.00

Book Value$125.95

EPS (TTM)$24.51

Company Overview

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 20.9%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 16.2%.

Consistent Profit Growth

Net profit has compounded at 12.6% per year over the last five years.

Reasonable Valuation

Trades at a P/E of 6.9, below the sector median of 25.2.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $17.36B (+9.7% YoY); net profit $1.49B.
Trailing 12 Months Year-on-year growth — revenue +8.3%, earnings +10.1%.
5-Year Trend Long-term compounding — revenue CAGR 8.8%, profit CAGR 12.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	8.80%
1 Year:	8.30%

Compounded Profit Growth

5 Years:	12.55%
1 Year:	10.10%

Stock Price Performance

1 Year:	-4.85%
6 Months:	-11.98%
3 Months:	+16.81%
1 Month:	-0.23%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed

52-Week Range 28% of range

$141.00 $243.12

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMABelow
RSI (14)50.07 · Neutral

Price Performance

1M-0.23%

3M+16.81%

6M-11.98%

1Y-4.85%

Valuation vs Sector

P/E of 6.90 is below the sector median of 25.17 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Strong return on equity of 20.9%.
Profit CAGR of 12.6% over 5 years.
Generates positive free cash flow.

CONS

Trading 30.4% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

6.90

Industry PE

25.17

Forward P/E

7.01

PEG Ratio

1.23

Book Value

$125.95

Price to Book

1.38

P/S

0.58

EV/EBITDA

5.79

Dividend Yield

0.47%

Growth (CAGR)

Revenue 5Y

8.80%

Profit 5Y

12.55%

Revenue (YoY)

8.30%

Earnings (YoY)

10.10%

Profitability & Returns

ROCE

16.23%

ROE

20.95%

ROA

8.32%

Profit Margin

8.42%

Op Margin

11.14%

Gross Margin

44.61%

EPS (Latest Qtr)

$5.98

EPS (TTM)

$24.51

Balance Sheet & Liquidity

Debt/Equity

0.69

Quick Ratio

0.89

Current Ratio

1.12

Debt

$5.26B

Total Assets

$15.94B

Current Assets

Working Capital

Ownership

Promoter Holding

4.98%

Chg in Prom Hold

0.15%

FII / Inst Holding

103.40%

Chg in FII Hold

-0.76%

Financial Snapshot

Enterprise Value

$9.01B

Total Revenue (TTM)

$18.11B

EBITDA

$2.70B

Free Cash Flow

$497.97M

Operating Cash Flow

$1.80B

Shares Outstanding

53.29M

Gross Margin

44.61%

Payout Ratio

3.27%

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	UHS Universal Health Services, Inc. SPXR3KPHARMA	169.14	6.90	$9.01B	0.47%	16.23%	20.95%	8.80%	12.55%
2	LLY Eli Lilly and Company SPXR3KPHARMA	1,149.36	38.57	$1.02T	0.58%	-	102.29%	7.20%	11.41%
3	JNJ Johnson & Johnson SPXR3KPHARMA	275.23	31.97	$663.28B	2.09%	14.88%	25.74%	2.43%	4.76%
4	ABBV AbbVie Inc. SPXR3KPHARMA	256.46	72.45	$453.19B	2.84%	10.47%	-129.24%	1.75%	-29.06%
5	MRK Merck & Co., Inc. SPXR3KPHARMA	150.33	120.26	$371.29B	2.65%	-	34.70%	5.64%	10.01%
6	UNH UnitedHealth Group Incorporated SPXR3KPHARMA	397.14	25.54	$356.47B	2.33%	9.74%	14.15%	10.40%	5.43%
7	NVS Novartis AG PHARMA	159.99	24.20	$304.10B	3.03%	21.09%	30.35%	9.25%	26.22%
8	AZN AstraZeneca PLC NDXPHARMA	162.70	24.36	$252.33B	1.98%	15.97%	21.96%	9.82%	45.96%
9	AMGN Amgen Inc. NDXSPXR3KPHARMA	437.23	27.14	$235.98B	2.49%	13.95%	91.47%	5.51%	5.55%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-	-	-	-	2.61B	2.61B	2.54B	2.64B	2.69B	2.68B	2.65B	2.75B	2.80B	2.86B	2.82B	2.90B	2.83B	2.73B	2.91B	3.09B	3.01B	3.20B	3.16B	3.29B	3.32B	3.34B	3.47B	3.55B	3.56B	3.84B	3.91B	3.96B	4.10B	4.28B	4.50B	4.50B	4.64B
Operating Income	335.39M	275.16M	-	356.32M	333.29M	277.57M	-	353.93M	330.19M	257.31M	-	333.81M	324.46M	257.16M	-	340.44M	345.56M	188.93M	-	236.69M	358.03M	349.67M	-	295.67M	438.97M	314.81M	232.86M	233.43M	275.88M	278.70M	280.13M	285.36M	388.76M	436.40M	384.17M	454.82M	500.27M	521.69M	502.86M	516.67M
Net Income	182.19M	150.29M	173.75M	190.76M	185.58M	151.87M	174.21M	206.06M	185.39M	141.25M	219.61M	223.83M	226.05M	171.75M	158.07M	234.17M	238.32M	97.19M	245.18M	142.04M	251.93M	241.28M	308.71M	209.09M	325.02M	218.35M	153.91M	164.06M	182.81M	163.12M	171.31M	166.99M	261.83M	289.15M	258.71M	316.68M	353.22M	372.96M	348.68M	358.45M
Diluted EPS	1.80	1.48	1.74	1.93	1.89	1.54	1.78	2.12	1.91	1.47	2.31	2.36	2.39	1.84	1.70	2.57	2.66	1.10	2.79	1.64	2.95	2.82	3.60	2.43	3.79	2.60	2.02	2.20	2.50	2.28	2.42	2.40	3.82	4.26	3.80	4.80	5.43	5.86	5.65	5.98

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	4.90B	6.76B	6.96B	7.37B	8.21B	9.04B	9.77B	10.41B	10.77B	11.38B	11.56B	12.64B	13.40B	14.28B	15.83B	17.36B
Operating Income	410.22M	520.53M	505.71M	897.13M	942.58M	1.02B	1.06B	1.26B	1.28B	1.28B	1.18B	1.22B	1.36B	1.36B	1.00B	1.18B	1.68B	1.99B
Net Income	199.38M	260.37M	230.18M	398.17M	443.45M	510.73M	545.34M	680.53M	702.41M	752.30M	779.71M	814.85M	943.95M	991.59M	675.61M	717.79M	1.14B	1.49B
Diluted EPS	1.96	2.64	2.34	4.04	4.53	5.14	5.42	6.76	7.14	7.81	8.31	9.13	10.99	11.82	9.14	10.23	16.82	23.10

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	3.96B	7.53B	7.67B	8.20B	8.31B	8.95B	9.62B	10.32B	10.76B	11.27B	11.67B	13.48B	13.09B	13.49B	13.97B	14.47B	15.53B
Total Equity	1.55B	1.58B	1.75B	1.98B	2.30B	2.71B	3.25B	3.74B	4.25B	4.53B	4.99B	5.39B	5.50B	6.32B	6.09B	5.92B	6.15B	6.67B	7.28B
Cash & Equivalents	16.35M	5.46M	9.18M	29.47M	41.23M	23.47M	17.24M	32.07M	61.23M	33.75M	74.42M	105.22M	61.27M	1.22B	115.30M	102.82M	119.44M	125.98M	137.80M
Long Term Debt	-	-	956.43M	3.91B	3.65B	3.73B	3.21B	3.21B	3.37B	4.03B	3.49B	3.94B	3.90B	3.52B	4.14B	4.73B	4.79B	4.46B	4.00B
Current Liabilities	-	-	582.82M	826.30M	836.93M	894.06M	1.06B	1.18B	1.10B	1.32B	1.85B	1.45B	1.56B	2.48B	1.98B	1.91B	2.01B	2.21B	3.24B

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	494.19M	541.26M	501.34M	710.68M	799.23M	884.24M	1.04B	1.07B	1.33B	1.25B	1.27B	1.44B	2.36B	883.70M	996.02M	1.27B	2.07B	1.86B
Investing Cash Flow	-295.67M	-390.43M	-2.19B	-285.81M	-789.59M	-383.46M	-832.85M	-912.88M	-1.16B	-684.73M	-747.25M	-688.41M	-802.56M	-914.47M	-647.30M	-763.27M	-911.11M	-1.07B
Financing Cash Flow	-209.41M	-147.11M	1.71B	-413.12M	-27.40M	-507.02M	-187.42M	-124.61M	-171.17M	-519.15M	-492.20M	-845.04M	-384.86M	-1.07B	-318.40M	-493.94M	-1.14B	-749.73M
Capital Expenditure	-354.54M	-379.75M	-239.27M	-285.68M	-363.19M	-358.49M	-391.15M	-379.32M	-519.94M	-557.51M	-664.96M	-634.10M	-731.31M	-855.66M	-734.00M	-743.05M	-943.81M	-1.02B
Free Cash Flow	139.65M	161.51M	262.07M	425.00M	436.04M	525.75M	644.73M	688.94M	813.90M	690.08M	609.78M	804.37M	1.63B	28.04M	262.02M	524.74M	1.12B	849.25M
Share Buybacks	149.40M	63.29M	11.53M	60.48M	19.15M	27.20M	100.75M	209.78M	353.38M	364.40M	397.43M	770.50M	206.72M	1.22B	832.92M	547.36M	670.75M	967.95M
Dividends Paid	16.15M	16.71M	19.42M	19.47M	58.40M	19.62M	29.66M	39.53M	38.88M	38.21M	37.34M	-	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Margin %	-	-	10.3%	13.3%	13.5%	13.8%	13.0%	13.9%	13.1%	12.3%	10.9%	10.7%	11.8%	10.8%	7.5%	8.2%	10.6%	11.5%
Net Margin %	-	-	4.7%	5.9%	6.4%	6.9%	6.6%	7.5%	7.2%	7.2%	7.2%	7.2%	8.2%	7.8%	5.0%	5.0%	7.2%	8.6%
ROE %	12.6%	14.9%	11.6%	17.3%	16.3%	15.7%	14.6%	16.0%	15.5%	15.1%	14.5%	14.8%	14.9%	16.3%	11.4%	11.7%	17.1%	20.5%
ROCE %	-	15.4%	7.5%	13.1%	12.9%	14.0%	13.7%	14.8%	14.2%	14.4%	12.0%	12.0%	12.4%	12.3%	8.7%	9.8%	13.7%	16.2%

Shareholding Pattern

Insiders

4.98%

Institutions

103.40%

Public Float

108.82%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	First Eagle Investment Management, LLC	8.81%	4.55M	$781.85M
2	Blackrock Inc.	7.85%	4.06M	$696.91M
3	Vanguard Capital Management LLC	6.56%	3.39M	$582.30M
4	Vanguard Portfolio Management LLC	4.74%	2.45M	$420.94M
5	Dimensional Fund Advisors LP	4.28%	2.21M	$379.47M
6	State Street Corporation	4.07%	2.10M	$360.93M
7	Geode Capital Management, LLC	3.82%	1.97M	$338.87M
8	Pzena Investment Management LLC	3.81%	1.97M	$338.05M
9	Invesco Ltd.	3.77%	1.95M	$334.93M
10	FMR, LLC	2.74%	1.42M	$243.20M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for UHS

Google News Sun, 06 Sep 2026

Universal Health Services (UHS) Stock Looks Cheap On Earnings While Returns Look Strong - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxQekF2TkZVSUZ1VnVHcDJrOXd2eDJvYkJ1aHdvZlBDTDdMc0lVeTE2LXdDbGtqUXAzN3A4b2RZSEhTYnp5YXZLMFNWbWE0S0V1SEY2T3gzRDF3U2dzTm1ESHhfZ0JOWFpNX0RUZjc4TkxYOXI0Nno0VXdtcWlhS2Q2dko0Nk1oZFQtUHh5RX…

Google News ue, 25 Aug 2026

Universal Health Services (UHS) Stock Looks Undervalued As Returns Already Look Strong - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPMmlwTDFXZjhOU0hLcWRCaUJVN2FFRFVlSFNuMjQ4S1UyTDVVNFhIdExhXzZhamlpUkVQQVVsMXZLV0dPcU45dEFiMGJ3YXRGUko5NHNLbS0xMDVpazB4UkxCM2VkNWtoS0RuenhBb1U4SHYzZVZadUk2S1p2T0tfTFRfaE1LOXJRRVNsX3…

Google News Mon, 27 Jul 2026

Universal Health Services (NYSE:UHS) Surprises With Q2 CY2026 Sales But Stock Drops - StockStory

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxQdkExVEV2NjdWSENyc2w2RGNCRnczWFJVSzN4RkdldVZWZVdCdVlOSzI1M2hCZ0dKeGt1Z2UwMWc2MURtQVdFX1JMNXFKTVZ3Sk1JU0syX1FyM2k0S1cwel9yYlRtVmViWC1mVENJZkdEM3F0VkM0bFFXcHNjNTAyV0cwMWtIc2ZiaFNMdj…

Google News Mon, 31 Aug 2026

UBS reiterates Universal Health Services stock rating at buy - Investing.com

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOeFFncG5wZHUwb3RFaDk3Szg5Sy1TYkdtV2NjSWV1b18yaU51bUdmRXBIeGRjbkZuYnd4dWFIdUR0MU1rU2ZGQ1lnUFp6RVlaN1ViYnJqaEM0NkpqUy00c2N6RkJPZl9PcGFNdU1GZkk1R3Ryd2R2S0RoWEo0S1lWZkZaR2ZpN0JQMWNMUE…

Google News ue, 25 Aug 2026

Universal Health Services Stock: Analyst Estimates & Ratings - Barchart.com

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOUjYtb3hleENoYnl5Vnk5R0Mxanl2ZFd4VDFrRFlIRVRYS21JcjJUWDJSaS12MWtxNU45bWdVRUNmLS1xNVF4OU4tQjBvYXRHTjBXVDZteURPanRwU3kyc095MzBucXBuTGgtbzExTGNhWDZQOUc4Rkw3X1lydFE2Z01wVnFic1VSaS05bH…

Google News Sat, 04 Jul 2026

Universal Health Services (UHS) Stock May Trade At A Discount On Medicare Payment News - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPdXlqdkF5Ml8zR0YzRm9oRUtYRDgwZzRsQXpLOUJXNHd2Zm5WeWJadVhOUzhYVHVldXcxQUZzUjdKNG1nbGlyX1hWbmtfRVgzRERXNmxkR0NQZEpDV2pyM3FJblFwMzFPX2kxTmhtUHM3T0xUZWFsRnUwS2E4Tnc1cmlRd0l5QlQ4MkFSbV…

UHS — Frequently Asked Questions

What is the current share price of Universal Health Services, Inc. (UHS)?

As of 2026-09-07 16:24 PDT, Universal Health Services, Inc. (UHS) trades at $169.14 on NYSE. Its 52-week range is $141.00 to $243.12.

What is the market capitalisation of UHS?

Universal Health Services, Inc. (UHS) has a market capitalisation of $9.01B on NYSE.

What is the P/E ratio of UHS?

UHS trades at a trailing price-to-earnings (P/E) ratio of 6.90. The industry average P/E is 25.17. Its price-to-book (P/B) ratio is 1.38.

Does UHS pay a dividend?

Universal Health Services, Inc. (UHS) currently offers a dividend yield of 0.47%.

What is the return on equity (ROE) of UHS?

UHS has a return on equity (ROE) of 20.95%. Its return on capital employed (ROCE) is 16.23%.

Is UHS a good stock to buy?

This page provides a data-driven analysis of Universal Health Services, Inc. (UHS), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Universal Health Services, Inc. UHS SPXR3KPHARMA

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Universal Health Services (UHS) Stock Looks Cheap On Earnings While Returns Look Strong - simplywall.st

Universal Health Services (UHS) Stock Looks Undervalued As Returns Already Look Strong - Yahoo Finance

Universal Health Services (NYSE:UHS) Surprises With Q2 CY2026 Sales But Stock Drops - StockStory

UBS reiterates Universal Health Services stock rating at buy - Investing.com

Universal Health Services Stock: Analyst Estimates & Ratings - Barchart.com

Universal Health Services (UHS) Stock May Trade At A Discount On Medicare Payment News - Yahoo Finance

UHS — Frequently Asked Questions

What is the current share price of Universal Health Services, Inc. (UHS)?

What is the market capitalisation of UHS?

What is the P/E ratio of UHS?

Does UHS pay a dividend?

What is the return on equity (ROE) of UHS?

Is UHS a good stock to buy?

Explore More